Grifols reported EUR269.48M in Selling and Administration Expenses for its fiscal quarter ending in December of 2024.


Selling And Administration Expenses Change Date
Alaunos Therapeutics USD 845K 162K Dec/2024
GlaxoSmithKline GBP 2.14B 80M Jun/2025
Grifols EUR 269.48M 49.95M Dec/2024
Life Technologies USD 4.93M 1.34M Jun/2025